Personalis Inc (OQ:PSNL)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for PSNL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Ricci Paul Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 11/20 Feb 7/20 Ludlum Ken Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -4,167  
Feb 11/20 Feb 7/20 Ludlum Ken Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,167 $3.80
Jan 9/20 Jan 7/20 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -12,000  
Jan 9/20 Jan 7/20 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 12,000 $0.440
Dec 26/19 Dec 20/19 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -12,000  
Dec 26/19 Dec 20/19 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 12,000 $0.440
Feb 14/20 Dec 13/19 Ricci Paul Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -1 $9.81
Dec 5/19 Dec 3/19 Tachibana Aaron Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 100,000  
Dec 5/19 Dec 3/19 Chen Richard Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 10,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PSNL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Ricci Paul Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Dec 13/19 Ricci Paul Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -1 $9.81
Feb 11/20 Feb 7/20 Ludlum Ken Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -4,167  
Feb 11/20 Feb 7/20 Ludlum Ken Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,167 $3.80
Jan 9/20 Jan 7/20 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -12,000  
Jan 9/20 Jan 7/20 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 12,000 $0.440
Dec 26/19 Dec 20/19 Chen Richard Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -12,000  
Dec 26/19 Dec 20/19 Chen Richard Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 12,000 $0.440
Dec 5/19 Dec 3/19 Tachibana Aaron Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 100,000  
Dec 5/19 Dec 3/19 Chen Richard Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 10,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PSNL

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Vir Biotechnology (OQ:VIR)
Alnylam Pharmaceuticals (OQ:ALNY)